Quarterly report pursuant to Section 13 or 15(d)

Segment reporting (Tables)

v2.4.1.9
Segment reporting (Tables)
6 Months Ended
Jan. 31, 2015
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block] The following financial information represents the operating results of the reportable segments of the Company:

Three months ended January 31, 2015                      
    Clinical
Labs
  Life
Sciences
  Therapeutics   Other   Consolidated  
Revenues:                                
Clinical laboratory services   $ 14,725               $ 14,725  
Product revenues       $ 7,723             7,723  
Royalty and license fee income         644             644  
      14,725     8,367             23,092  
Operating expenses:                                
Cost of clinical laboratory services     9,246                 9,246  
Cost of product revenues         3,818             3,818  
Research and development         635   $ 199         834  
Selling, general and administrative     5,089     2,704       $ 1,877     9,670  
Provision for uncollectible accounts receivable     658     (57 )           601  
Legal fee expense     41     (53 )       2,816     2,804  
Total operating expenses     15,034     7,047     199     4,693     26,973  
                                 
Operating income (loss)     (309 )   1,320     (199 )   (4,693 )   (3,881 )
                                 
Other income (expense)                                
Interest     (12 )   5         (42 )   (49 )
Other     4     (29 )       8     (17 )
Foreign exchange loss         (259 )           (259 )
Income (loss) before income taxes   $ (317 ) $ 1,037   $ (199 ) $ (4,727 ) $ (4,206 )
                                 
Depreciation and amortization included above   $ 357   $ 555   $ 1   $ 22   $ 935  
                                 
Share-based compensation included in above:                                
Cost of clinical laboratory services   $ 2               $ 2  
Research and development       $ 1             1  
Selling, general and administrative     12     3       $ 87     102  
Total   $ 14   $ 4       $ 87   $ 105  
                                 
Capital expenditures   $ 338   $ 51   $   $   $ 389  
Three months ended January 31, 2014
                     
    Clinical
Labs
  Life
Sciences
  Therapeutics   Other   Consolidated  
Revenues:                                
Clinical laboratory services   $ 13,848               $ 13,848  
Product revenues       $ 8,054             8,054  
Royalty and license fee income         1,026             1,026  
      13,848     9,080             22,928  
Operating expenses:                                
Cost of clinical laboratory services     9,292                 9,292  
Cost of product revenues         3,865             3,865  
Research and development     3     543   $ 286         832  
Selling, general and administrative     4,981     3,318       $ 1,785     10,084  
Provision for uncollectible accounts receivable     920     (8 )           912  
Legal fee expense     142     15         1,339     1,496  
Total operating expenses     15,338     7,733     286     3,124     26,481  
                                 
Operating income (loss)     (1,490 )   1,347     (286 )   (3,124 )   (3,553 )
                                 
Other income (expense)                                
Interest     (11 )   3          (44 )   (52 )
Other     9     (6 )       12     15  
Foreign exchange gain         20             20  
Income (loss) before income taxes   $ (1,492 ) $ 1,364   $ (286 ) $ (3,156 ) $ (3,570 )
                                 
Depreciation and amortization included above   $ 355   $ 621   $ 2   $ 24   $ 1,002  
                                 
Share-based compensation included in above:                                
Cost of clinical laboratory services   $ 2               $ 2  
Research and development                      
Selling, general and administrative     9   $ 5       $ 93     107  
Total   $ 11   $ 5       $ 93   $ 109  
                                 
Capital expenditures   $ 103   $ 7   $   $   $ 110  
Six months ended January 31, 2015                                
    Clinical
Labs
  Life
Sciences
  Therapeutics   Other   Consolidated  
Revenues:                                
Clinical laboratory services   $ 30,547               $ 30,547  
Product revenues       $ 15,725             15,725  
Royalty and license fee income         1,644             1,644  
      30,547     17,369             47,916  
Operating expenses:                                
Cost of clinical laboratory services     19,376                 19,376  
Cost of product revenues         7,513             7,513  
Research and development         1,183   $ 442         1,625  
Selling, general and administrative     10,157     5,853       $ 3,945     19,955  
Provision for uncollectible accounts receivable     1,189     (47 )           1,142  
Legal     131     (51 )       5,190     5,270  
Total operating expenses     30,853     14,451     442     9,135     54,881  
                                 
Operating income (loss)     (306 )   2,918     (442 )   (9,135 )   (6,965 )
                                 
Other income (expense)                                
Interest     (39 )   7         (86 )   (118 )
Other     6     (35 )       31     2  
Foreign exchange gain         (731 )           (731
Income (loss) before income taxes   $ (339 ) $ 2,159   $ (442 ) $ (9,190 ) $ (7,812 )
                                 
Depreciation and amortization included above   $ 714   $ 1,113   $ 2   $ 44   $ 1,873  
                                 
Share-based compensation included in above:                                
Cost of clinical laboratory services   $ 3               $ 3  
Research and development       $ 2             2  
Selling, general and administrative     21     3       $ 174     198  
Total   $ 24   $ 5       $ 174   $ 203  
                                 
Capital expenditures   $ 589   $ 64   $   $   $ 653  
Six months ended January 31, 2014                                
    Clinical
Labs
  Life
Sciences
  Therapeutics   Other   Consolidated  
Revenues:                                
Clinical laboratory services   $ 28,707               $ 28,707  
Product revenues       $ 15,717             15,717  
Royalty and license fee income         2,637             2,637  
      28,707     18,354             47,061  
Operating expenses:                                
Cost of clinical laboratory services     19,001                 19,001  
Cost of product revenues         7,712             7,712  
Research and development     14     1,069   $ 566         1,649  
Selling, general and administrative     10,031     6,813       $ 3,768     20,612  
Provision for uncollectible accounts receivable     1,764     20             1,784  
Legal     290     37         2,550     2,877  
Total operating expenses     31,100     15,651     566     6,318     53,635  
                                 
Operating income (loss)     (2,393 )   2,703     (566 )   (6,318 )   (6,574 )
                                 
Other income (expense)                                
Interest     (22 )   8         (100)     (114 )
Other     27     21         28     76  
Foreign exchange gain         317             317  
Income (loss) before income taxes   $ (2,388 ) $ 3,049   $ (566 ) $ (6,390 ) $ (6,295 )
                                 
Depreciation and amortization included above   $ 710   $ 1,262   $ 6   $ 49   $ 2,027  
                                 
Share-based compensation included in above:                                
Cost of clinical laboratory services   $ 4               $ 4  
Research and development       $ 1             1  
Selling, general and administrative     19     9       $ 179     207  
Total   $ 23   $ 10       $ 179   $ 212  
                                 
Capital expenditures   $ 362   $ 82   $   $   $ 444